M. Kihiko-Ehmann

Insulysin Hydrolyzes Amyloid β Peptides to Products That Are Neither Neurotoxic Nor Deposit on Amyloid Plaques

L. Hersh, S. Estus, A. Mukherjee, 2000, The Journal of Neuroscience.

Urokinase‐type plasminogen activator inhibits amyloid‐β neurotoxicity and fibrillogenesis via plasminogen

S. Estus, M. Kihiko-Ehmann, H. Tucker, 2002, Journal of neuroscience research.

Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice

S. Younkin, L. Younkin, J. Simpson, 2004, Neuroscience Letters.

Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid‐β Neurotoxicity and Deposition

S. Estus, R. Rydel, S. Wright, 2000, Journal of neurochemistry.